173 related articles for article (PubMed ID: 24106410)
1. Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation.
Yan XD; Yao M; Wang L; Zhang HJ; Yan MJ; Gu X; Shi Y; Chen J; Dong ZZ; Yao DF
World J Gastroenterol; 2013 Sep; 19(36):6084-92. PubMed ID: 24106410
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma.
Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411
[TBL] [Abstract][Full Text] [Related]
3. Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma.
Yao M; Yao DF; Bian YZ; Zhang CG; Qiu LW; Wu W; Sai WL; Yang JL; Zhang HJ
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):289-94. PubMed ID: 21669573
[TBL] [Abstract][Full Text] [Related]
4. Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development.
Qiu LW; Yao DF; Zong L; Lu YY; Huang H; Wu W; Wu XH
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):406-11. PubMed ID: 18693177
[TBL] [Abstract][Full Text] [Related]
5. Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation.
Sai WL; Yao M; Shen SJ; Zheng WJ; Sun JY; Wu MN; Wang L; Yao DF
Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):449-454. PubMed ID: 32171652
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis.
Wu W; Yao DF; Qiu LW; Sai WL; Shen JJ; Yu HB; Wu XH; Li YM; Wang YL; Gu WJ
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):504-9. PubMed ID: 19822494
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of
Zheng WJ; Yao M; Fang M; Wang L; Dong ZZ; Yao DF
World J Gastroenterol; 2018 Aug; 24(32):3650-3662. PubMed ID: 30166860
[TBL] [Abstract][Full Text] [Related]
8. Alteration of oncogenic IGF-II gene methylation status associates with hepatocyte malignant transformation.
Tai BJ; Yao M; Zheng WJ; Shen YC; Wang L; Sun JY; Wu MN; Dong ZZ; Yao DF
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):158-163. PubMed ID: 30692043
[TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of insulin-like growth factor-I receptor in hepatoma tissue and its inhibition to promote apoptosis of tumor cells.
Dong Z; Yao M; Wang L; Yan X; Gu X; Shi Y; Yao N; Qiu L; Wu W; Yao D
Tumour Biol; 2013 Dec; 34(6):3397-405. PubMed ID: 23797814
[TBL] [Abstract][Full Text] [Related]
10. [Dynamic expression of carnitine palmitoyltransferase II in the mitochondrial inner membrane during hepatocyte malignant transformation induced by lipid accumulation].
Gu JJ; Yao M; Cai Y; Fang M; Wang L; Zheng WJ; Yao DB; Dong ZZ; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):279-284. PubMed ID: 28494547
[No Abstract] [Full Text] [Related]
11. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao DB; Wu XH; Wu W; Qiu LW; Jiang DR; Zhu JH; Meng XY
World J Gastroenterol; 2005 Aug; 11(30):4655-60. PubMed ID: 16094705
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis.
Gu JJ; Yao M; Yang J; Cai Y; Zheng WJ; Wang L; Yao DB; Yao DF
World J Gastroenterol; 2017 Jan; 23(2):256-264. PubMed ID: 28127199
[TBL] [Abstract][Full Text] [Related]
13. [Abnormal expression of insulin-like growth factor-I receptor and inhibitory effect of its transcription intervention on nude mice xenograft tumor].
Yao M; Yan XD; Cai Y; Gu JJ; Yang XL; Pan LH; Wang L; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):846-851. PubMed ID: 27978931
[No Abstract] [Full Text] [Related]
14. IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo.
Yao M; Wang L; Yang J; Yan X; Cai Y; Yao D
Tumour Biol; 2016 Nov; 37(11):14677-14686. PubMed ID: 27623941
[TBL] [Abstract][Full Text] [Related]
15. Effects of insulin-like growth factors-IR and -IIR antisense gene transfection on the biological behaviors of SMMC-7721 human hepatoma cells.
Yang JM; Chen WS; Liu ZP; Luo YH; Liu WW
J Gastroenterol Hepatol; 2003 Mar; 18(3):296-301. PubMed ID: 12603530
[TBL] [Abstract][Full Text] [Related]
16. Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.
Huang X; Yu C; Jin C; Yang C; Xie R; Cao D; Wang F; McKeehan WL
Mol Carcinog; 2006 Dec; 45(12):934-42. PubMed ID: 16929488
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic Wnt3a is a promising sensitive biomarker for monitoring hepatocarcinogenesis.
Yao M; Wang JJ; Chen XY; Sai WL; Yang J; Wang DF; Wang L; Yao DF
Hepatobiliary Pancreat Dis Int; 2023 Jun; 22(3):263-269. PubMed ID: 36435702
[TBL] [Abstract][Full Text] [Related]
18. Increased hepatic expression of insulin-like growth factor-I receptor in chronic hepatitis C.
Stefano JT; Correa-Giannella ML; Ribeiro CM; Alves VA; Massarollo PC; Machado MC; Giannella-Neto D
World J Gastroenterol; 2006 Jun; 12(24):3821-8. PubMed ID: 16804965
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma.
Sue SR; Chari RS; Kong FM; Mills JJ; Fine RL; Jirtle RL; Meyers WC
Ann Surg; 1995 Aug; 222(2):171-8. PubMed ID: 7639583
[TBL] [Abstract][Full Text] [Related]
20. Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma.
Yao DF; Wu W; Yao M; Qiu LW; Wu XH; Su XQ; Zou L; Yao DB; Meng XY
World J Gastroenterol; 2006 Aug; 12(31):4966-72. PubMed ID: 16937491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
